Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0005783 | endoplasmic reticulum | 5 | 1 |
GO:0005794 | Golgi apparatus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: E9AIR6
Term | Name | Level | Count |
---|---|---|---|
GO:0006497 | protein lipidation | 5 | 1 |
GO:0006605 | protein targeting | 5 | 1 |
GO:0006612 | protein targeting to membrane | 5 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0006810 | transport | 3 | 1 |
GO:0006886 | intracellular protein transport | 4 | 1 |
GO:0006897 | endocytosis | 5 | 1 |
GO:0008104 | protein localization | 4 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0015031 | protein transport | 4 | 1 |
GO:0016192 | vesicle-mediated transport | 4 | 1 |
GO:0018193 | peptidyl-amino acid modification | 5 | 1 |
GO:0018198 | peptidyl-cysteine modification | 6 | 1 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 7 | 1 |
GO:0018231 | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 7 | 1 |
GO:0018345 | protein palmitoylation | 6 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0033036 | macromolecule localization | 2 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043543 | protein acylation | 5 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0045184 | establishment of protein localization | 3 | 1 |
GO:0046907 | intracellular transport | 3 | 1 |
GO:0051179 | localization | 1 | 1 |
GO:0051234 | establishment of localization | 2 | 1 |
GO:0051641 | cellular localization | 2 | 1 |
GO:0051649 | establishment of localization in cell | 3 | 1 |
GO:0051668 | localization within membrane | 3 | 1 |
GO:0070727 | cellular macromolecule localization | 3 | 1 |
GO:0071702 | organic substance transport | 4 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0071705 | nitrogen compound transport | 4 | 1 |
GO:0072657 | protein localization to membrane | 4 | 1 |
GO:0090150 | establishment of protein localization to membrane | 4 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0016409 | palmitoyltransferase activity | 5 | 11 |
GO:0016417 | S-acyltransferase activity | 5 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016746 | acyltransferase activity | 3 | 11 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 11 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 4 | 11 |
GO:0019707 | protein-cysteine S-acyltransferase activity | 3 | 11 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 217 | 221 | PF00656 | 0.512 |
CLV_C14_Caspase3-7 | 269 | 273 | PF00656 | 0.568 |
CLV_NRD_NRD_1 | 113 | 115 | PF00675 | 0.225 |
CLV_PCSK_KEX2_1 | 113 | 115 | PF00082 | 0.225 |
CLV_PCSK_PC7_1 | 109 | 115 | PF00082 | 0.238 |
CLV_PCSK_SKI1_1 | 214 | 218 | PF00082 | 0.242 |
CLV_PCSK_SKI1_1 | 240 | 244 | PF00082 | 0.227 |
DEG_MDM2_SWIB_1 | 134 | 142 | PF02201 | 0.299 |
DOC_MAPK_gen_1 | 128 | 137 | PF00069 | 0.428 |
DOC_MAPK_gen_1 | 255 | 263 | PF00069 | 0.548 |
DOC_MAPK_MEF2A_6 | 131 | 139 | PF00069 | 0.360 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.280 |
DOC_USP7_MATH_1 | 63 | 67 | PF00917 | 0.634 |
DOC_USP7_MATH_1 | 9 | 13 | PF00917 | 0.174 |
LIG_14-3-3_CanoR_1 | 255 | 263 | PF00244 | 0.609 |
LIG_BRCT_BRCA1_1 | 11 | 15 | PF00533 | 0.300 |
LIG_BRCT_BRCA1_1 | 193 | 197 | PF00533 | 0.317 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.267 |
LIG_FHA_1 | 175 | 181 | PF00498 | 0.236 |
LIG_FHA_1 | 207 | 213 | PF00498 | 0.500 |
LIG_FHA_1 | 257 | 263 | PF00498 | 0.647 |
LIG_FHA_1 | 281 | 287 | PF00498 | 0.544 |
LIG_FHA_1 | 30 | 36 | PF00498 | 0.295 |
LIG_FHA_1 | 8 | 14 | PF00498 | 0.252 |
LIG_FHA_2 | 215 | 221 | PF00498 | 0.418 |
LIG_FHA_2 | 255 | 261 | PF00498 | 0.617 |
LIG_FHA_2 | 279 | 285 | PF00498 | 0.615 |
LIG_GBD_Chelix_1 | 136 | 144 | PF00786 | 0.387 |
LIG_LIR_Gen_1 | 12 | 23 | PF02991 | 0.368 |
LIG_LIR_Gen_1 | 132 | 142 | PF02991 | 0.350 |
LIG_LIR_Nem_3 | 12 | 18 | PF02991 | 0.285 |
LIG_LIR_Nem_3 | 132 | 137 | PF02991 | 0.274 |
LIG_LIR_Nem_3 | 194 | 200 | PF02991 | 0.404 |
LIG_MYND_1 | 275 | 279 | PF01753 | 0.561 |
LIG_PCNA_yPIPBox_3 | 153 | 164 | PF02747 | 0.228 |
LIG_Pex14_2 | 134 | 138 | PF04695 | 0.298 |
LIG_SH2_CRK | 99 | 103 | PF00017 | 0.421 |
LIG_SH2_SRC | 210 | 213 | PF00017 | 0.472 |
LIG_SH2_STAP1 | 91 | 95 | PF00017 | 0.512 |
LIG_SH2_STAT3 | 73 | 76 | PF00017 | 0.496 |
LIG_SH2_STAT5 | 106 | 109 | PF00017 | 0.525 |
LIG_SH2_STAT5 | 133 | 136 | PF00017 | 0.299 |
LIG_SH2_STAT5 | 184 | 187 | PF00017 | 0.231 |
LIG_SH2_STAT5 | 210 | 213 | PF00017 | 0.512 |
LIG_SH2_STAT5 | 73 | 76 | PF00017 | 0.525 |
LIG_SH3_1 | 53 | 59 | PF00018 | 0.637 |
LIG_SH3_3 | 272 | 278 | PF00018 | 0.592 |
LIG_SH3_3 | 52 | 58 | PF00018 | 0.582 |
LIG_SH3_3 | 92 | 98 | PF00018 | 0.360 |
LIG_SUMO_SIM_anti_2 | 187 | 194 | PF11976 | 0.219 |
LIG_SUMO_SIM_anti_2 | 36 | 41 | PF11976 | 0.259 |
LIG_SUMO_SIM_anti_2 | 4 | 10 | PF11976 | 0.267 |
LIG_SUMO_SIM_par_1 | 187 | 194 | PF11976 | 0.261 |
LIG_SUMO_SIM_par_1 | 4 | 10 | PF11976 | 0.290 |
LIG_TRFH_1 | 184 | 188 | PF08558 | 0.160 |
LIG_WRC_WIRS_1 | 192 | 197 | PF05994 | 0.387 |
LIG_WRPW_2 | 96 | 99 | PF00400 | 0.512 |
MOD_CK1_1 | 163 | 169 | PF00069 | 0.297 |
MOD_CK1_1 | 174 | 180 | PF00069 | 0.249 |
MOD_CK2_1 | 164 | 170 | PF00069 | 0.177 |
MOD_CK2_1 | 254 | 260 | PF00069 | 0.550 |
MOD_CK2_1 | 278 | 284 | PF00069 | 0.552 |
MOD_GlcNHglycan | 173 | 176 | PF01048 | 0.454 |
MOD_GlcNHglycan | 177 | 180 | PF01048 | 0.444 |
MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.335 |
MOD_GSK3_1 | 160 | 167 | PF00069 | 0.231 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.248 |
MOD_GSK3_1 | 206 | 213 | PF00069 | 0.311 |
MOD_GSK3_1 | 250 | 257 | PF00069 | 0.585 |
MOD_GSK3_1 | 278 | 285 | PF00069 | 0.677 |
MOD_GSK3_1 | 29 | 36 | PF00069 | 0.381 |
MOD_LATS_1 | 162 | 168 | PF00433 | 0.177 |
MOD_N-GLC_1 | 214 | 219 | PF02516 | 0.218 |
MOD_N-GLC_2 | 266 | 268 | PF02516 | 0.351 |
MOD_N-GLC_2 | 292 | 294 | PF02516 | 0.331 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.256 |
MOD_NEK2_1 | 143 | 148 | PF00069 | 0.283 |
MOD_NEK2_1 | 180 | 185 | PF00069 | 0.230 |
MOD_NEK2_1 | 200 | 205 | PF00069 | 0.397 |
MOD_NEK2_1 | 206 | 211 | PF00069 | 0.331 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.256 |
MOD_OFUCOSY | 118 | 124 | PF10250 | 0.218 |
MOD_PK_1 | 164 | 170 | PF00069 | 0.275 |
MOD_PKA_2 | 160 | 166 | PF00069 | 0.288 |
MOD_PKA_2 | 171 | 177 | PF00069 | 0.192 |
MOD_PKA_2 | 254 | 260 | PF00069 | 0.522 |
MOD_Plk_4 | 1 | 7 | PF00069 | 0.287 |
MOD_Plk_4 | 138 | 144 | PF00069 | 0.270 |
MOD_Plk_4 | 151 | 157 | PF00069 | 0.229 |
MOD_Plk_4 | 191 | 197 | PF00069 | 0.389 |
MOD_Plk_4 | 206 | 212 | PF00069 | 0.251 |
MOD_Plk_4 | 231 | 237 | PF00069 | 0.545 |
MOD_Plk_4 | 9 | 15 | PF00069 | 0.256 |
TRG_ENDOCYTIC_2 | 133 | 136 | PF00928 | 0.255 |
TRG_ENDOCYTIC_2 | 99 | 102 | PF00928 | 0.421 |
TRG_Pf-PMV_PEXEL_1 | 223 | 227 | PF00026 | 0.415 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5B1 | Leptomonas seymouri | 24% | 100% |
A0A0N1I542 | Leptomonas seymouri | 60% | 100% |
A0A0S4IT15 | Bodo saltans | 26% | 83% |
A0A0S4J156 | Bodo saltans | 30% | 82% |
A0A0S4JRL4 | Bodo saltans | 27% | 82% |
A0A1X0NY30 | Trypanosomatidae | 41% | 97% |
A0A3R7P4J6 | Trypanosoma rangeli | 38% | 99% |
A0A3S7WZD9 | Leishmania donovani | 80% | 91% |
A4H7G8 | Leishmania braziliensis | 28% | 100% |
A4I1S8 | Leishmania infantum | 81% | 91% |
B3DN87 | Arabidopsis thaliana | 25% | 88% |
C9ZKD6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 96% |
E9AXW2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 91% |
F1R013 | Danio rerio | 29% | 77% |
O14345 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 24% | 90% |
O74384 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 28% | 85% |
O80685 | Arabidopsis thaliana | 29% | 72% |
P59267 | Mus musculus | 27% | 81% |
P59268 | Mus musculus | 26% | 81% |
Q0WQK2 | Arabidopsis thaliana | 32% | 67% |
Q14AK4 | Mus musculus | 24% | 85% |
Q2TGJ1 | Rattus norvegicus | 30% | 77% |
Q3EBC2 | Arabidopsis thaliana | 26% | 75% |
Q4Q9K8 | Leishmania major | 78% | 100% |
Q58CU4 | Bos taurus | 26% | 79% |
Q58DA8 | Bos taurus | 26% | 82% |
Q5PNZ1 | Arabidopsis thaliana | 25% | 72% |
Q5R5J8 | Pongo abelii | 26% | 81% |
Q5Y5T2 | Mus musculus | 30% | 78% |
Q6BHT4 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 25% | 80% |
Q6CG20 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 25% | 78% |
Q6CQB5 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 28% | 83% |
Q75CB4 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 27% | 79% |
Q7ZVN4 | Danio rerio | 27% | 76% |
Q8VYS8 | Arabidopsis thaliana | 29% | 73% |
Q9FLM3 | Arabidopsis thaliana | 30% | 72% |
Q9JKR5 | Rattus norvegicus | 27% | 81% |
Q9NUE0 | Homo sapiens | 27% | 76% |
Q9SB58 | Arabidopsis thaliana | 30% | 73% |
Q9UIJ5 | Homo sapiens | 26% | 81% |
Q9Y397 | Homo sapiens | 26% | 81% |
V5BCH8 | Trypanosoma cruzi | 42% | 99% |